Drawing for VEBREZE

USPTO serial 77129803

VEBREZE

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
CHANG, KATHERINE S
Law office
PETITIONS OFFICE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VEBREZE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bruce W. Longbottom

BRUCE W. LONGBOTTOM ELI LILLY AND COMPANYLILLY CORPORATE CTRINDIANAPOLIS, IN 46285-0001UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Dry powder form of insulinABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 3, 2008MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
Jan 3, 2008ABN5ABANDONMENT - AFTER PUBLICATION—
Dec 4, 2007EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Oct 9, 2007ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Sep 11, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 22, 2007NPUBNOTICE OF PUBLICATION—
Aug 7, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 7, 2007ALIEASSIGNED TO LIE—
Jun 22, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 21, 2007DOCKASSIGNED TO EXAMINER—
Mar 16, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance